{"transactions":[{"id":1935849,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":115022,"kind":"person","name":"Evans Thomas George","position":1,"cik":"0001851686","reported_name":"Evans Thomas George","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Fmr Chief Scientific Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2023-03-29T16:43:22.000Z","date":"2023-01-03","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable in three equal annual installments, with the first installment vesting on January 3, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":125000,"derivative":{"exercise_price":2.4,"expiration_date":"2033-01-03","underlying":"Ordinary Shares","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001104659-23-038362","document":"tm2310913-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851686/000110465923038362/tm2310913-2_4seq1.xml","form_type":"4"}},{"id":2401974,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":115022,"kind":"person","name":"Evans Thomas George","position":1,"cik":"0001851686","reported_name":"Evans Thomas George","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2022-02-11T19:54:09.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable in three equal annual installments, with the first installment vesting on January 3, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":80000,"derivative":{"exercise_price":11.12,"expiration_date":"2032-01-03","underlying":"Ordinary Shares","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001104659-22-020823","document":"tm226469-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851686/000110465922020823/tm226469-4_4seq1.xml","form_type":"4"}},{"id":2730517,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":115022,"kind":"person","name":"Evans Thomas George","position":1,"cik":"0001851686","reported_name":"Evans Thomas George","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2021-05-04T20:23:15.000Z","date":"2021-04-29","kind":"grant","acquired":true,"shares":364620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option shall vest and become exercisable in three equal annual installments, with the first installment vesting on April 29, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":364620,"derivative":{"exercise_price":17,"expiration_date":"2031-04-29","underlying":"Ordinary Shares","underlying_shares":364620},"source":{"system":"sec-edgar","filing":"0001104659-21-061219","document":"tm2114558-16_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851686/000110465921061219/tm2114558-16_4seq1.xml","form_type":"4"}},{"id":2730516,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":115022,"kind":"person","name":"Evans Thomas George","position":1,"cik":"0001851686","reported_name":"Evans Thomas George","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2021-05-04T20:23:15.000Z","date":"2021-04-29","kind":"grant","acquired":true,"shares":6942,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable on April 29, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":6942,"derivative":{"exercise_price":17,"expiration_date":"2031-04-29","underlying":"Ordinary Shares","underlying_shares":6942},"source":{"system":"sec-edgar","filing":"0001104659-21-061219","document":"tm2114558-16_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851686/000110465921061219/tm2114558-16_4seq1.xml","form_type":"4"}}]}